Peter Hodsman

829 total citations
18 papers, 677 citations indexed

About

Peter Hodsman is a scholar working on Surgery, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Hodsman has authored 18 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Pharmacology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Hodsman's work include Pain Management and Opioid Use (2 papers), Anesthesia and Pain Management (2 papers) and Computational Drug Discovery Methods (2 papers). Peter Hodsman is often cited by papers focused on Pain Management and Opioid Use (2 papers), Anesthesia and Pain Management (2 papers) and Computational Drug Discovery Methods (2 papers). Peter Hodsman collaborates with scholars based in United States, Australia and United Kingdom. Peter Hodsman's co-authors include Rosemary Ffrench, Jason A. Tye–Din, Revati Shreeniwas, Matthew Siegel, Robert P. Anderson, Gregor J. Brown, Paddy A. Phillips, Masahiro Kohzuki, Colin I. Johnston and Bruno Fabris and has published in prestigious journals such as Blood, PLoS ONE and The American Journal of Medicine.

In The Last Decade

Peter Hodsman

18 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Hodsman United States	11	120	120	109	99	93	18	677
Ingrid M. C. Kamerling Netherlands	14	116 1.0×	107 0.9×	82 0.8×	172 1.7×	28 0.3×	42	658
P. Bäumer France	13	75 0.6×	106 0.9×	108 1.0×	41 0.4×	79 0.8×	27	781
W. A. Stack United Kingdom	14	119 1.0×	302 2.5×	89 0.8×	74 0.7×	49 0.5×	25	809
Prabhat Ranjan India	13	360 3.0×	145 1.2×	65 0.6×	68 0.7×	74 0.8×	34	732
Yoshihiro Kawabata Japan	14	68 0.6×	86 0.7×	69 0.6×	43 0.4×	23 0.2×	58	635
Jianyi Yin United States	17	301 2.5×	68 0.6×	67 0.6×	79 0.8×	30 0.3×	32	844
Michela Schäppi Switzerland	16	280 2.3×	93 0.8×	112 1.0×	295 3.0×	52 0.6×	27	1.2k
Sanxia Wang United States	12	202 1.7×	27 0.2×	114 1.0×	24 0.2×	55 0.6×	20	885
Marco Bertini Italy	17	143 1.2×	90 0.8×	368 3.4×	63 0.6×	19 0.2×	38	1.1k

Countries citing papers authored by Peter Hodsman

Since Specialization

Citations

This map shows the geographic impact of Peter Hodsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hodsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hodsman more than expected).

Fields of papers citing papers by Peter Hodsman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hodsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hodsman. The network helps show where Peter Hodsman may publish in the future.

Co-authorship network of co-authors of Peter Hodsman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hodsman. A scholar is included among the top collaborators of Peter Hodsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hodsman. Peter Hodsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Dockendorf, Marissa F., John Palcza, Jack Tseng, et al.. (2018). Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study. Clinical Pharmacology & Therapeutics. 105(5). 1234–1243. 18 indexed citations

Khalilieh, Sauzanne, et al.. (2018). Pharmacokinetics of Tildrakizumab (MK‐3222), an Anti‐IL‐23 Monoclonal Antibody, After Intravenous or Subcutaneous Administration in Healthy Subjects. Basic & Clinical Pharmacology & Toxicology. 123(3). 294–300. 30 indexed citations

Brigandi, Richard A., et al.. (2014). Intravenous pharmacokinetics, local tolerability, and hemolysis of an SBE7‐β‐cyclodextrin formulation of the neurokinin‐1 receptor antagonist vestipitant. Clinical Pharmacology in Drug Development. 4(2). 130–136. 6 indexed citations

O’Riordan, Thomas G., Peter Hodsman, John H. Ansede, et al.. (2013). Acute Hyperkalemia Associated with Inhalation of a Potent ENaC Antagonist: Phase 1 Trial of GS-9411. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(3). 200–208. 45 indexed citations

Martin, Kévin, et al.. (2013). Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects. Nephrology Dialysis Transplantation. 29(2). 385–392. 49 indexed citations

Hodsman, Peter, et al.. (2012). A phase 1, randomized, placebo‐controlled, dose‐escalation study of an anti‐IL‐13 monoclonal antibody in healthy subjects and mild asthmatics. British Journal of Clinical Pharmacology. 75(1). 118–128. 50 indexed citations

Forman, Mark S., Marissa F. Dockendorf, John Palcza, et al.. (2012). P1‐225: A study to evaluate the pharmacokinetics and pharmacodynamics of single and multiple oral doses of the novel BACE inhibitor MK‐8931 in Japanese subjects. Alzheimer s & Dementia. 8(4S_Part_5). 3 indexed citations

Fisher, Darrell R., et al.. (2012). First-in-man evaluation of PF329, a abuse-resistant prodrug of hydromorphone. Journal of Pain. 13(4). S76–S76. 1 indexed citations

Price, Clare F., David Tyssen, Secondo Sonza, et al.. (2011). SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans. PLoS ONE. 6(9). e24095–e24095. 136 indexed citations

10.

Banfield, Christopher, Jane R. Parnes, Maurice G. Emery, et al.. (2010). Single-Dose, First-in-Human Study Of AMG 853: Pharmacokinetics, Pharmacodynamics, And Safety In Healthy Adults. A5397–A5397. 3 indexed citations

11.

Banfield, Christopher, et al.. (2010). Single-Dose, First-in-Human Study of AMG 853: Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Adults. Journal of Allergy and Clinical Immunology. 125(2). AB66–AB66. 3 indexed citations

12.

Hodsman, Peter, et al.. (2010). An Open-Label, Single Ascending Dose Phase I Study of F-627, a G-CSF Dimer, In Healthy Male Subjects. Blood. 116(21). 4722–4722. 2 indexed citations

13.

Tye–Din, Jason A., Robert P. Anderson, Rosemary Ffrench, et al.. (2009). The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clinical Immunology. 134(3). 289–295. 125 indexed citations

14.

Clemens, Pamela L., Jong-Soon Park, Marvin B. Cohen, et al.. (2009). Abstract A101: BMS-754807, an oral dual IGF-1R/IR inhibitor: First-in-human single-dose study of safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects. Molecular Cancer Therapeutics. 8(12_Supplement). A101–A101. 2 indexed citations

15.

Kerr, Robert O., et al.. (1997). Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain. Journal of Pain and Symptom Management. 14(2). 63–73. 58 indexed citations

16.

Johnston, Colin I., Peter Hodsman, Masahiro Kohzuki, et al.. (1989). Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. The American Journal of Medicine. 87(6). 24S–28S. 88 indexed citations

17.

Jackson, B., et al.. (1988). Changes in the Renin--Angiotensin System, Exchangeable Body Sodium, and Plasma and Atrial Content of Atrial Natriuretic Factor During Evolution of Chronic Renal Failure in the Rat. American Journal of Hypertension. 1(3 Pt 1). 298–300. 10 indexed citations

18.

Cleland, John G.F., P F Semple, Peter Hodsman, et al.. (1984). Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure. The American Journal of Medicine. 77(5). 880–886. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact